| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pain | D010146 | 64 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Pain, Postoperative | D010149 | 13 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Uveitis | D014605 | 14 associated lipids |
Resolvin d1
Resolvin d1 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Resolvin d1
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Resolvin d1
PubChem Biomolecular Interactions and Pathways
All references with Resolvin d1
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rossi S et al. | Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages. | 2015 | Mediators Inflamm. | pmid:25684860 |
| Cox R et al. | Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. | 2015 | Am. J. Respir. Cell Mol. Biol. | pmid:25647402 |
| Lastrucci C et al. | Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues. | 2015 | FASEB J. | pmid:25609430 |
| Pierdomenico AM et al. | MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages. | 2015 | J. Biol. Chem. | pmid:25505240 |
| Harrison JL et al. | Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. | 2015 | Brain Behav. Immun. | pmid:25585137 |
| Hua J et al. | The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. | 2014 | Invest. Ophthalmol. Vis. Sci. | pmid:25146982 |
| Arnardottir HH et al. | Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. | 2014 | J. Immunol. | pmid:25217168 |
| Li L et al. | Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells. | 2014 | J Neuroinflammation | pmid:24708771 |
| Martin CR et al. | Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. | 2014 | PLoS ONE | pmid:24892762 |
| Mirakaj V et al. | Vagus nerve controls resolution and pro-resolving mediators of inflammation. | 2014 | J. Exp. Med. | pmid:24863066 |
| McCauley LK et al. | Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2. | 2014 | J. Immunol. | pmid:24890726 |
| Leigh NJ et al. | Expression of resolvin D1 biosynthetic pathways in salivary epithelium. | 2014 | J. Dent. Res. | pmid:24389810 |
| Aursnes M et al. | Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions. | 2014 | J. Nat. Prod. | pmid:24576195 |
| Wang Q et al. | Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury. | 2014 | J. Immunol. | pmid:24646745 |
| Chen J et al. | Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24709673 |
| Recchiuti A et al. | Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. | 2014 | FASEB J. | pmid:24692596 |
| Nelson JW et al. | ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. | 2014 | Am. J. Physiol., Cell Physiol. | pmid:24259417 |
| Shinohara M et al. | Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. | 2014 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:25217660 |
| Chen F et al. | Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. | 2014 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:24072678 |
| Tang H et al. | Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. | 2014 | J. Immunol. | pmid:25172497 |